Givaudan
This article was originally published in The Rose Sheet
Executive Summary
Annual sales increased 6% to $1.4 bil. (CHF 1=$.585) and net profit improved 14% to $155 mil. Despite growth, fragrance sales dropped 2% in local currencies to $6.4 mil. due to shortfall in consumer products segment and reduction in sales of pharmaceutical raw materials and UV sunscreen filter to Roche, Givaudan says. In June, the fragrance and flavors division was spun off from Roche as an independent company (1"The Rose Sheet" June 19, 2000, In Brief)
You may also be interested in...
Givaudan
Fragrances and flavors supplier stock closed at approximately $312.50 (510 CHF) on its first day of trading on the Swiss Market Index June 8. Givaudan Roure's former parent company, Roche, voted to spin off the company at its May 9 general assembly; each Roche stockholder will receive one share of GIVN. Roche announced the $3.41 bil. transaction in December (1"The Rose Sheet" Dec. 13, 1999, p. 6). The new company, which will be renamed Givaudan, will continue to be headed by CEO Jurg Witmer. Givaudan generated $1.37 bil. in sales in 1999 and estimates it holds 14% of the worldwide flavors and fragrances market
OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"
With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program
Beauty Claims Inch Closer To Pharma As Cosmeceutical Sector Expands
Though global market-size estimates differ, analysts at SupplySide West 2010 in Las Vegas agreed that cosmeceuticals remain a promising growth vehicle